Skip to content
Governance Register

Company · London Liquidation

Reviral Limited

Research and experimental development on biotechnology

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Reviral Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 20

  1. Naveed Siddiqi 2021-2022 Director View profile
  2. Yi Zhou 2020-2022 Director View profile
  3. Ronald Martin Hunt 2020-2022 Director View profile
  4. Dr Lawrence Blatt 2019-2022 Director View profile
  5. Richard Kender 2019-2022 Director View profile
  6. Alex Sapir 2019-2022 Director View profile
  7. Dr Isaac Andrew Manke 2018-2020 Director View profile
  8. Dr Nanna Liebach LÜNeborg 2018-2021 Director View profile
  9. Dr Edward Littler 2016-2019 Director View profile
  10. Dr Iain David Dukes 2016-2022 Director View profile
  11. Chau Q. Khuong 2015-2022 Director View profile
  12. Professor Raymond Schinazi 2015-2019 Director View profile
  13. Dr Kenneth Leslie Powell 2015-2022 Director View profile
  14. Dr Timothy Jinks 2015-2018 Director View profile
  15. Raphael Wisniewski 2015-2022 Director View profile
  16. Nikos Nassuphis 2014-2015 Director View profile
  17. Khattereh Ahmadi 2011-2015 Director View profile
  18. George Stuart Cockerill 2011-2018 Director View profile
  19. Richard Angell 2011-2013 Director View profile
  20. Michael Jones 2011-2015 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Research and experimental development on biotechnology
Incorporated
10/01/2011
Registered office
London
Previous names
RE:Viral Limited (until 08/12/2015)
RE-Viral Limited (until 24/01/2011)

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Reviral Limited is controlled by Pfizer Specialty UK Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2022-06-09 · source: Companies House PSC register

Ultimately controlled by Pfizer Specialty UK Limited.

1 other company in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

4.1y median 4.1y
average tenure
4.1y
longest tenure
0
directors past 6 years

First-time vs portfolio directors

Portfolio (2)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 13Manufacturing 4Retail and trade 4Business services 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
07486063
Status
Liquidation
Type
Private Limited Company
Accounts next due
28/02/2026
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data